Dr. Heloisa Soares
Claim this profileHuntsman Cancer Institute/University of Utah
Expert in Neuroendocrine Tumors
Studies Colorectal Cancer
25 reported clinical trials
50 drugs studied
About Heloisa Soares
Education:
- Earned an MD from the Federal University of Rio de Janeiro, Brazil (2007).
- Completed Residency in Internal Medicine at the University of São Paulo, Brazil (2008-2010).
- Undertook a Fellowship in Hematology and Oncology at the University of São Paulo, Brazil (2011-2013).
- Completed a Postdoctoral Research Fellowship at the Huntsman Cancer Institute/University of Utah (2014-2016).
Experience:
- Has been an Assistant Professor of Internal Medicine at the Huntsman Cancer Institute/University of Utah since 2016.
- Specializes in cancer research with a focus on hematology and oncology.
Area of expertise
1Neuroendocrine Tumors
Global LeaderStage IV
Stage III
SSTR positive
2Colorectal Cancer
Stage IV
dMMR negative
MSI-H negative
Affiliated Hospitals
Clinical Trials Heloisa Soares is currently running
Triapine + Targeted Radiation
for Neuroendocrine Cancer
This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking tumors or slowing tumor growth in patients with neuroendocrine tumors that have spread from where they first started (primary site) to other places in the body (metastatic). Triapine may stop the growth of tumor cells by blocking some of the enzymes needed for deoxyribonucleic acid synthesis and cell growth. Lutetium Lu 177 dotatate is a radioactive drug. It binds to a protein called somatostatin receptor, which is found on some neuroendocrine tumor cells. Lutetium Lu 177 dotatate builds up in these cells and gives off radiation that may kill them. It is a type of radioconjugate and a type of somatostatin analog. Giving triapine in combination with lutetium Lu 177 dotatate may be more effective at shrinking tumors or slowing tumor growth in patients with metastatic neuroendocrine tumors than the standard therapy of lutetium Lu 177 dotatate alone.
Recruiting1 award Phase 2
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
More about Heloisa Soares
Clinical Trial Related2 years of experience running clinical trials · Led 25 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Heloisa Soares has experience with
- Lutetium Lu 177 Dotatate
- Capecitabine
- Temozolomide
- Bevacizumab
- Everolimus
- Fluorouracil
Breakdown of trials Heloisa Soares has run
Neuroendocrine Tumors
Colorectal Cancer
Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heloisa Soares specialize in?
Heloisa Soares focuses on Neuroendocrine Tumors and Colorectal Cancer. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Heloisa Soares currently recruiting for clinical trials?
Yes, Heloisa Soares is currently recruiting for 11 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Heloisa Soares has studied deeply?
Yes, Heloisa Soares has studied treatments such as Lutetium Lu 177 Dotatate, Capecitabine, Temozolomide.
What is the best way to schedule an appointment with Heloisa Soares?
Apply for one of the trials that Heloisa Soares is conducting.
What is the office address of Heloisa Soares?
The office of Heloisa Soares is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.